• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SOLEVA PHARMA LLC MUGARD ORAL RINSE 240ML/BTL; DRESSING, WOUND AND BURN, HYDROGEL W/DRUG AND/OR BIOLOGIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SOLEVA PHARMA LLC MUGARD ORAL RINSE 240ML/BTL; DRESSING, WOUND AND BURN, HYDROGEL W/DRUG AND/OR BIOLOGIC Back to Search Results
Patient Problem Insufficient Information (4580)
Event Type  Death  
Event Description
Caregiver (b)(6) reported that the pt has passed away on (b)(6) 2023.Swish and expel or swallow 5 to 10 ml 4 to 6 times daily as prescribed for management of oral mucositis.Prescriber contact info: (b)(6).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MUGARD ORAL RINSE 240ML/BTL
Type of Device
DRESSING, WOUND AND BURN, HYDROGEL W/DRUG AND/OR BIOLOGIC
Manufacturer (Section D)
SOLEVA PHARMA LLC
MDR Report Key17957361
MDR Text Key325943613
Report NumberMW5147065
Device Sequence Number1
Product Code MGQ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 10/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/17/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Patient Sequence Number1
Patient Outcome(s) Death;
Patient SexMale
-
-